A Study of Venetoclax and ABBV-838 Combination Therapy With Dexamethasone in Participants With Multiple Myeloma Whose Cancer Has Come Back or Had No Response to Recent Cancer Treatment
Clinical trial NCT02951117 · WITHDRAWN
Trial details
- NCT number
- NCT02951117
- Sponsor
- AbbVie
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-31
- Primary completion
- 2020-07-28
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.